Differential caspase‐9‐dependent signaling pathway between tumor necrosis factor receptor‐ and Fas‐mediated hepatocyte apoptosis in mice
Authors:
- 18 November 2005
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 26 (1) , 137-146
Abstract
Abstract: Background/Aims: Two apoptosis signaling pathways, which are used by different cell types, are identified. The activation of caspases is critical for the apoptosis process. The aim of this study was to investigate the effects of the caspase‐9 inhibitor Ac‐LEHD‐CHO on tumor necrosis factor receptor (TNFR)‐ and Fas‐mediated hepatocyte apoptosis in vivo, in order to evaluate the similarities and distinctions between TNFR‐ and Fas‐mediated signaling pathways.Methods: BALB/c mice were intravenously injected with d‐galactosamine (GalN, 20 mg/mouse)/tumor necrosis factor‐α (TNF‐α, 0.5 μg/mouse), or αFas (10 μg/mouse) 30 min after treatment with the caspase‐9 inhibitor Ac‐LEHD‐CHO or pan‐caspase inhibitor Z‐VAD‐fmk. Liver injury was assessed biochemically and histologically. Cytochrome c release and processing of procaspases in the liver were analyzed by Western blotting. Activities of caspases were measured using a fluorogenic peptide substrate.Results: Pretreatment with Z‐VAD‐fmk prevented liver injury and hepatocyte apoptosis induced by either GalN/TNF‐α or αFas. On the other hand, pretreatment with Ac‐LEHD‐CHO prevented GalN/TNF‐α‐induced hepatotoxicity and hepatocyte apoptosis but not αFas‐induced liver injury and apoptosis. Both inhibitors reduced the activities of caspase‐9 and ‐3 in the livers of mice administered by GalN/TNF‐α. However, unlike Z‐VAD‐fmk, Ac‐LEHD‐CHO did not inhibit caspase‐3 activation in αFas‐treated mice, although this inhibitor attenuated caspase‐9.Conclusion: Fas may rely on both caspase‐8 activation (extrinsic pathway) and mitochondria (intrinsic pathway) to activate caspase‐3. If the mitochondria‐dependent pathway is blocked, the other pathway can compensate. In contrast, TNFR may mediate hepatocellular apoptosis mainly through the mitochondria‐mediated caspase‐9 activation pathway alone.Keywords
This publication has 23 references indexed in Scilit:
- Differential Protection with Inhibitors of Caspase-8 and Caspase-3 in Murine Models of Tumor Necrosis Factor and Fas Receptor-Mediated Hepatocellular ApoptosisToxicology and Applied Pharmacology, 2001
- Letter to the EditorCell Death & Differentiation, 1999
- Cell Death in DevelopmentCell, 1999
- Three-dimensional structures of proteins involved in programmed cell deathJournal of Molecular Biology, 1997
- Apoptosis by Death FactorCell, 1997
- A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.Journal of Experimental Medicine, 1996
- Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in miceGastroenterology, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.Journal of Experimental Medicine, 1994
- Lethal effect of the anti-Fas antibody in miceNature, 1993